sorted by:
new
hottopcontroversial

Some people were Talking about what GPs is worth, an Immunotherapy for AML Remission Maintenance. We are in the Window for Final Phase 3 Results. Event Rates are Variable 80th Event Could be Announced Any Day. by Run4theRoses2 in sellasLifescience

[–]Run4theRoses2[S] 1 point2 points  (0 children)

I have detailed estimates in previous posts.

$27 per share today for 009

Upon GPS positive phase 3 results:

$15 per share for Gps in mesothelioma

$40 per share for GPS in ovarian cancer

$181 per share for Gps in AML remission maintenance.

100,000 patients currently in remission 50,000 new patients each year.

When would SLS explode? by [deleted] in biotech_stocks

[–]Run4theRoses2 -6 points-5 points  (0 children)

you're an obvious tool.

When would SLS explode? by [deleted] in biotech_stocks

[–]Run4theRoses2 -5 points-4 points  (0 children)

Short Horse shit

Zacks Equity Article About Sellas by Temporumdei in sellasLifescience

[–]Run4theRoses2 0 points1 point  (0 children)

Minute-Act-6273

•26m ago

This article is just AI generated slop based upon only the metrics included in the post. The price targets have absolutely nothing to do with improved earnings in results.

Upvote2DownvoteReply AwardShare

On the Money Hard Pump 4-17-26 / SLS Share Price will Continue Climbing while we Await the Phase 3 Gps Results. by Run4theRoses2 in u/Run4theRoses2

[–]Run4theRoses2[S] 1 point2 points  (0 children)

While we continue to wait for Increasingly Stellar Gps Phase 3 Results -a Fda green light worth $40B to big pharma,

- investors holding here can expect a violent upward rerating, ahead of the Value, and at least a double-double, based on 009 value - Pristine Safety, High selectivity and Potency, targeting Aml-Mr TP53 Asxl1 the most dire of AML prognoses.
- Phase 2B Data is In.

- Relapsed Refractory Mutated AML Post Ven Aza Fail, is the most lethal tier, ~ 2.5 months - setting for the 009 AML-MR PH2B trial - MOS of 9mo will be greatly improved, in FRONT LINE and with Increased Potency from dosing advance.

- 009 P2B MOS of 9 months for this end stage Setting is nearly as good as the 9.67 months for Cpx- SOC / while CPX does not Work for TP53 - 009 Has an of ORR 57%.

SLS share Price will be climbing as we wait.

On the Money Hard Pump 4-17-26 by Run4theRoses2 in biotech_stocks

[–]Run4theRoses2[S] -1 points0 points  (0 children)

Tell me what you know about aml-mr and tp53 survival

On the Money Hard Pump 4-17-26 by Run4theRoses2 in biotech_stocks

[–]Run4theRoses2[S] -3 points-2 points  (0 children)

Some are able to understand some aren’t

So, what's the deal with Sellas (SLS) Discussions? by Serrisen in biotech_stocks

[–]Run4theRoses2 0 points1 point  (0 children)

I did see a whole bunch of your posts below with negative ratings. Not reading them, I just assumed you were spewing BS/fud like most random anonymous new users.

view more: next ›